If you are seeing this message, you may be experiencing temporary network problems. Please wait a
few minutes and refresh the page. If the problem persists, you may wish to report it to your local
Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise
these problems.
Wiley InterScience Exhaled breath condensate pH and ammonia in cystic fibrosis and response to treatment of acute pulmonary exacerbations
Sharon Newport, MD * Division of Pediatric Pulmonology, Maria Fareri Children's Hospital at Westchester Medical Center and New York Medical College, Valhalla, New York email: Sharon Newport (sharonann@optonline.net )
*
cystic fibrosis • exhaled breath condensate • ammonia
Exhaled breath condensate (EBC) pH reflects the acid-base homeostasis of the airway lining fluid and is up to 3 log order lower in various inflammatory lung diseases including asthma, COPD, bronchiectasis, and cystic fibrosis (CF) than in normal controls. The aim of this study was to confirm this finding in CF and determine if there was a significant change in EBC pH after treatment of an acute pulmonary exacerbation. Ten subjects with CF and a pulmonary exacerbation, and 10 healthy age-matched control subjects were studied. EBC was collected at the onset of an acute pulmonary exacerbation and after treatment with intravenous antibiotics (median duration: 14 days (interquartile range, IQR): 12-14) when the exacerbation was considered resolved. The median age for CF patients was 15.9 years (IQR: 13-18.8), compared to 18 years (IQR: 15-24.8) for the control group, P = 0.242. All CF subjects had severe lung disease, median FEV1 = 41.5% of predicted (IQR: 30.8-46.5%). Median EBC pH in CF subjects at the onset of a pulmonary exacerbation was 6.61 (IQR: 6.17-7.91) compared to median EBC pH of 8.14 (IQR: 7.45-9.08) in the control group, P < 0.02. Median EBC pH after resolution of an exacerbation was 7.02 (IQR: 5.8-8.64), not significantly different (P = 0.667) than during the acute exacerbation. EBC pH decreased in five subjects, increased in three subjects and there was no change in two subjects. There was no correlation between EBC pH and FEV1 either before or after intravenous antibiotics. EBC ammonia, an important buffer of ASL, was also measured and similarly found to be lower than in normal controls. EBC pH is lower in CF than age-matched controls, and did not change consistently in response to treatment of an acute pulmonary exacerbation. Pediatr Pulmonol. 2009; 44:866-872. © 2009 Wiley-Liss, Inc.
Received: 15 October 2008; Revised: 16 February 2009; Accepted: 21 February 2009
10.1002/ppul.21078
About DOI
Related Articles Find other articles like this in Wiley InterScience Find articles in Wiley InterScience written by any of the authors Wiley InterScience is a member of CrossRef.
Reach the world with your research
Your article can enjoy free open access
and reach global readers if published in Thoracic Cancer
Submit your paper today!
